quinacrine has been researched along with organophosphonates in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keister, DL; Raveed, NJ | 1 |
| Davies, JE; Jennings, SC; Ng, LL; Pettit, AI; Quinn, PA; Wong, RK | 1 |
2 other study(ies) available for quinacrine and organophosphonates
| Article | Year |
|---|---|
Energy-linked reactions in photosynthetic bacteria. IX. Pi-PPi exchange in Rhodospirillum rubrum.
Topics: Antimycin A; Bacterial Chromatophores; Chromatography, Ion Exchange; Chromatography, Thin Layer; Cyanides; Darkness; Diphosphates; Fluorides; Kinetics; Light; Magnesium; Oligomycins; Organophosphonates; Phenylhydrazines; Phosphates; Phosphorus Radioisotopes; Quinacrine; Rhodospirillum rubrum; Time Factors; Uncoupling Agents | 1974 |
Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic Acid.
Topics: Acetylcysteine; Adult; Arachidonic Acid; Arachidonic Acids; Cells, Cultured; Enzyme Inhibitors; Glycation End Products, Advanced; Group IV Phospholipases A2; Humans; Indomethacin; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Organophosphonates; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Quinacrine; Reactive Oxygen Species; Respiratory Burst; Vascular Diseases | 2003 |